Hematopoietic potential of stem cells isolated from murine skeletal muscle - PubMed (original) (raw)
Hematopoietic potential of stem cells isolated from murine skeletal muscle
K A Jackson et al. Proc Natl Acad Sci U S A. 1999.
Abstract
We have discovered that cells derived from the skeletal muscle of adult mice contain a remarkable capacity for hematopoietic differentiation. Cells prepared from muscle by enzymatic digestion and 5-day in vitro culture were harvested, and 18 x 10(3) cells were introduced into each of six lethally irradiated recipients together with 200 x 10(3) distinguishable whole bone marrow cells. After 6 or 12 weeks, all recipients showed high-level engraftment of muscle-derived cells representing all major adult blood lineages. The mean total contribution of muscle cell progeny to peripheral blood was 56 +/- 20% (SD), indicating that the cultured muscle cells generated approximately 10- to 14-fold more hematopoietic activity than whole bone marrow. When bone marrow from one mouse was harvested and transplanted into secondary recipients, all recipients showed high-level multilineage engraftment (mean 40%), establishing the extremely primitive nature of these stem cells. We also show that muscle contains a population of cells with several characteristics of bone marrow-derived hematopoietic stem cells, including high efflux of the fluorescent dye Hoechst 33342 and expression of the stem cell antigens Sca-1 and c-Kit, although the cells lack the hematopoietic marker CD45. We propose that this population accounts for the hematopoietic activity generated by cultured skeletal muscle. These putative stem cells may be identical to muscle satellite cells, some of which lack myogenic regulators and could be expected to respond to hematopoietic signals.
Figures
Figure 1
Flow cytometric analysis of peripheral blood from a representative mouse transplanted with muscle cells. Peripheral blood was drawn from the transplant recipient 6 weeks after it received 18 × 103 Ly-5.1+ mononuclear muscle cells and 200 × 103 Ly-5.2+ whole bone marrow cells and then was stained with anti-Ly-5.1-biotin followed by Str-PE and antibodies to specific lineage markers. (A–C) Controls. (B–F) Peripheral blood from transplant recipient. (A) C57BL/6-Ly-5.2 peripheral blood stained with anti-Ly-5.1-biotin followed by Str-PE. (B) C57BL/6-Ly-5.1 peripheral blood stained with anti-Ly-5.1-biotin + Str-PE. (C) C57BL/6-Ly-5.1 peripheral blood stained with isotype controls for lineage markers (a mixture of rat-IgG2a-FITC and rat-IgG2b-FITC). (D) Anti-B220-FITC (B cells) with anti-Ly-5.1-biotin + Str-PE. (E) Anti-Thy-1-FITC (T cells) with anti-Ly-5.1 biotin + Str-PE. (F) Anti-Gr-1-FITC + anti-Mac-1-FITC (granulocytes and macrophages, respectively) with anti-Ly-5.1-biotin + Str-PE. The percentage of cells in each quadrant is indicated in the Upper Right corner. Bracketed numbers (D–F) are the percentages of lineage-positive cells derived from muscle. This calculation was made by dividing the number of cells in the Upper Right quadrant by the total number of lineage-positive cells (the sum of both Right quadrants).
Figure 2
Multilineage engraftment in all mice transplanted with muscle cells. Peripheral blood was drawn 6 and 12 weeks after transplantation and stained with antibodies against the Ly-5.1 marker, B220 (B cells), Thy-1 (T cells), and Gr-1 and Mac-1 (granulocytes and macrophages, respectively). Stained blood samples were analyzed by flow cytometry, as described in Experimental Procedures. The percentages of positive cells in each lineage are reported. Mouse 1 (M1) was killed after the 6-week analysis for subsequent study (Fig. 3).
Figure 3
Repopulation of lymphoid and myeloid cell compartments in secondary recipients of muscle cells. Bone marrow from mouse 1 (M1; Fig. 2) was transplanted at 8 × 105 nucleated cells per mouse into each of five lethally irradiated C57BL/6-Ly-5.2 recipients. After 5 weeks, peripheral blood was drawn and stained with antibodies against Ly-5.1, B220 (B cells), Thy-1 (T cells), and Gr-1/Mac-1 (granulocytes and macrophages) and then analyzed by flow cytometry. The findings are displayed as the percentages of cells positive for Ly-5.1 and specific lineage markers.
Figure 4
Flow cytometric analysis of HSC from secondary recipients of muscle cells. Bone marrow prepared from the secondary transplant recipient mouse 5 (Fig. 3) was stained with Hoechst 33342, anti-Ly-5.1-biotin, and Str-PE. (A and B) Whole bone marrow. (C and D) HSC. Whole bone marrow contained 0.03% HSC (determined by Hoechst dye efflux; refs. and 22) and contained 63% Ly-5.1+ cells (B). The HSC population (C) contained 65% Ly-5.1+ cells (D).
Figure 5
Flow cytometric analysis of muscle cell cultures. (A, C, and E) Whole culture. (B, D, and F) Hoechst low SP cells. The percentage of cells in each quadrant is indicated in the Upper Right corner. (A) Whole muscle cell culture stained with Hoechst 33342. The indicated region is analogous to the SP fraction of whole bone marrow and represents about 1% of the culture. (B) SP fraction as gated in A. (C) Whole culture stained with anti-Sca-1-FITC and anti-CD45-biotin + Str-PE. (D) Anti-Sca-1-FITC and anti-CD45 staining of the SP fraction. (E) Whole culture stained with anti-c-Kit-PE alone. (F) c-Kit staining of the SP fraction.
Comment in
- The power of stem cells reconsidered?
Lemischka I. Lemischka I. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14193-5. doi: 10.1073/pnas.96.25.14193. Proc Natl Acad Sci U S A. 1999. PMID: 10588676 Free PMC article. No abstract available.
Similar articles
- Stem cell plasticity in muscle and bone marrow.
Goodell MA, Jackson KA, Majka SM, Mi T, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK. Goodell MA, et al. Ann N Y Acad Sci. 2001 Jun;938:208-18; discussion 218-20. doi: 10.1111/j.1749-6632.2001.tb03591.x. Ann N Y Acad Sci. 2001. PMID: 11458510 Review. - Muscle-derived hematopoietic stem cells are hematopoietic in origin.
McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. McKinney-Freeman SL, et al. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1341-6. doi: 10.1073/pnas.032438799. Proc Natl Acad Sci U S A. 2002. PMID: 11830662 Free PMC article. - Hematopoietic potential of murine skeletal muscle-derived CD45(-)Sca-1(+)c-kit(-) cells.
Howell JC, Yoder MC, Srour EF. Howell JC, et al. Exp Hematol. 2002 Aug;30(8):915-24. doi: 10.1016/s0301-472x(02)00872-x. Exp Hematol. 2002. PMID: 12160843 - Altered phenotype and reduced function of muscle-derived hematopoietic stem cells.
McKinney-Freeman SL, Majka SM, Jackson KA, Norwood K, Hirschi KK, Goodell MA. McKinney-Freeman SL, et al. Exp Hematol. 2003 Sep;31(9):806-14. doi: 10.1016/s0301-472x(03)00186-3. Exp Hematol. 2003. PMID: 12962727 - Stem cells in adult skeletal muscle.
Asakura A. Asakura A. Trends Cardiovasc Med. 2003 Apr;13(3):123-8. doi: 10.1016/s1050-1738(03)00024-0. Trends Cardiovasc Med. 2003. PMID: 12691677 Review.
Cited by
- The impact of acute and chronic aerobic and resistance exercise on stem cell mobilization: A review of effects in healthy and diseased individuals across different age groups.
Li W, Chen L, Mohammad Sajadi S, Baghaei S, Salahshour S. Li W, et al. Regen Ther. 2024 May 7;27:464-481. doi: 10.1016/j.reth.2024.04.013. eCollection 2024 Dec. Regen Ther. 2024. PMID: 38745840 Free PMC article. - Accumulation of Dystrophin-Positive Muscle Fibers and Improvement of Neuromuscular Junctions in mdx Mouse Muscles after Bone Marrow Transplantation under Different Conditions.
Sokolova AV, Domnina AP, Mikhailov VM. Sokolova AV, et al. Int J Mol Sci. 2023 May 17;24(10):8892. doi: 10.3390/ijms24108892. Int J Mol Sci. 2023. PMID: 37240237 Free PMC article. - The role and therapeutic potential of stem cells in skeletal muscle in sarcopenia.
Cai Z, Liu D, Yang Y, Xie W, He M, Yu D, Wu Y, Wang X, Xiao W, Li Y. Cai Z, et al. Stem Cell Res Ther. 2022 Jan 24;13(1):28. doi: 10.1186/s13287-022-02706-5. Stem Cell Res Ther. 2022. PMID: 35073997 Free PMC article. Review. - Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways.
Charrier M, Lorant J, Contreras-Lopez R, Téjédor G, Blanquart C, Lieubeau B, Schleder C, Leroux I, Deshayes S, Fonteneau JF, Babarit C, Hamel A, Magot A, Péréon Y, Viau S, Delorme B, Luz-Crawford P, Lamirault G, Djouad F, Rouger K. Charrier M, et al. Stem Cell Res Ther. 2022 Jan 10;13(1):7. doi: 10.1186/s13287-021-02681-3. Stem Cell Res Ther. 2022. PMID: 35012660 Free PMC article. - Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.
Pacheco-Herrero M, Soto-Rojas LO, Reyes-Sabater H, Garcés-Ramirez L, de la Cruz López F, Villanueva-Fierro I, Luna-Muñoz J. Pacheco-Herrero M, et al. J Alzheimers Dis. 2021;84(3):917-935. doi: 10.3233/JAD-200863. J Alzheimers Dis. 2021. PMID: 34633316 Free PMC article. Review.
References
- Spangrude G J, Smith L, Uchida N, Ikuta K, Heimfeld S, Friedman J, Weissman I L. Blood. 1991;78:1395–1402. - PubMed
- Gage F H, Ray J, Fisher L J. Annu Rev Neurosci. 1995;18:159–192. - PubMed
- Rudland P S. Cancer Metastasis Rev. 1987;6:55–83. - PubMed
- Sigal S H, Brill S, Fiorino A S, Reid L M. Am J Physiol. 1992;263:G139–G148. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous